Disordered mineral metabolism produced by ketogenic diet therapy

[1]  S. Teitelbaum,et al.  Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro. , 1978, The Journal of clinical investigation.

[2]  M. Haymond,et al.  The clinical and biochemical implications of pyruvate carboxylase deficiency. , 1977, The Journal of clinical endocrinology and metabolism.

[3]  M. Haussler,et al.  Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. , 1977, The Journal of clinical endocrinology and metabolism.

[4]  J. Ferrendelli,et al.  CHRONIC KETOSIS AND CEREBRAL METABOLISM , 1977, Pediatric Research.

[5]  L. Avioli,et al.  25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. , 1977, Science.

[6]  P. Huttenlocher.  Ketonemia and Seizures: Metabolic and Anticonvulsant Effects of Two Ketogenic Diets in Childhood Epilepsy , 1976, Pediatric Research.

[7]  P. D. de Moor,et al.  The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. , 1975, The Journal of clinical endocrinology and metabolism.

[8]  D. Devivo,et al.  Starvation and seizures. Observation on the electroconvulsive threshold and cerebral metabolism of the starved adult rat. , 1975, Archives of neurology.

[9]  E. Iisalo,et al.  Prophylactic fluoride treatment and aged bones. , 1975, British medical journal.

[10]  J. A. Madsen,et al.  Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. , 1975, Pediatrics.

[11]  J. Haddad,et al.  Serum 25-Hydroxycalciferol Levels and Bone Mass in Children on Chronic Anticonvulsant Therapy , 1975 .

[12]  C. Christiansen,et al.  IATROGENIC OSTEOMALACIA IN EPILEPTIC CHILDREN , 1975 .

[13]  L. Avioli,et al.  Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. , 1974, The Journal of clinical endocrinology and metabolism.

[14]  G. Neale,et al.  Effect of phenobarbitone treatment on vitamin D metabolism in mammals. , 1974, Clinical science and molecular medicine.

[15]  C. Christiansen,et al.  Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial , 1973, British medical journal.

[16]  N. Maclaren,et al.  Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. , 1973, The Journal of pediatrics.

[17]  K. Schaefer,et al.  Influence of Diphenylhydantoin and Phenobarbital on Intestinal Calcium Transport in the Rat * , 1972, Epilepsia.

[18]  L. Avioli,et al.  Phenobarbital-induced alterations in vitamin D metabolism. , 1972, The Journal of clinical investigation.

[19]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[20]  P. Huttenlocher,et al.  Medium‐chain triglycerides as a therapy for intractable childhood epilepsy , 1971, Neurology.

[21]  J. Pennell,et al.  On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. , 1971, The Journal of clinical investigation.

[22]  A. Richens,et al.  Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy , 1970, British medical journal.

[23]  A. Richens,et al.  Disturbance of Calcium Metabolism by Anticonvulsant Drugs , 1970, British medical journal.

[24]  L. Avioli,et al.  Nondialyzable urinary hydroxyproline as an index of bone collagen formation. , 1970, The Journal of clinical endocrinology and metabolism.

[25]  J. Lemann,et al.  The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. , 1966, The Journal of clinical investigation.

[26]  A. Sjoerdsma,et al.  Hydroxyproline and Collagen Metabolism: Clinical Implications: Combined Clinical Staff Conference at the National Institutes of Health , 1965 .

[27]  F. Lafferty,et al.  CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER. , 1964, Metabolism: clinical and experimental.

[28]  C. W. Gottschalk,et al.  Micropuncture study of renal tubular reabsorption of calcium in normal rodents , 1963 .

[29]  S. Udenfriend,et al.  A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.

[30]  M. Wills,et al.  The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: Adenosine 3′, 5′ cyclic monophosphate production , 2005, Calcified Tissue Research.

[31]  C. Christiansen,et al.  Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial. , 1975, Acta paediatrica Scandinavica.

[32]  J. Haddad,et al.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol. , 1971, The Journal of clinical endocrinology and metabolism.